‘Viread’ positioned the top among imported products while anticancer and vaccines in top ranking

Published: 2016-03-02 14:23:11

Updated: 2016-03-02 14:23:11

The reputation of hepatitis B treatments was still solid.

This is because ‘Viread(sold by Gilead and Yuhan Corporation)’ and ‘Baraclude(sold by BMS Korea, and sold by Green Cross from September last year)’ took the 1^st and 2^nd respectively in the imported drugs in Korea last year.

Moreover, the increase of anticancer imports has also attracted attentions under the coverage strengthening pol...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.